| Literature DB >> 33547405 |
Leeann R Pavlek1,2, Julie Dillard3, Gregory Ryshen4, Emily Hone5, Edward G Shepherd6, Mohannad Moallem5.
Abstract
OBJECTIVE: To describe characteristics associated with repeated unplanned extubations, short-term complications and outcomes, and longer-term morbidities including acquired subglottic stenosis. STUDYEntities:
Year: 2021 PMID: 33547405 PMCID: PMC7862843 DOI: 10.1038/s41372-021-00927-9
Source DB: PubMed Journal: J Perinatol ISSN: 0743-8346 Impact factor: 2.521
Overall patient demographics and comparison between 1 UE and ≥2 UE groups.
| Parameter | Total ( | 1 UE ( | ≥2 UE ( | |
|---|---|---|---|---|
| Male sex | 183 (61.0%) | 96 (57.5%) | 87 (65.4%) | 0.19 |
| Gestational age at birth (weeks) | 26.7 (24.6; 33.1) | 28.0 (25.4; 37.0) | 25.4 (24.0; 27.9) | |
| Postmenstrual age at first UE (weeks) | 34.3 (28.8; 39.8) | 36.4 (30.4; 40.1) | 32.1 (27.7; 38.6) | |
| Birth weight (g) | 859.0 (615.0; 1964.0) | 1069.0 (695.0; 2490.0) | 743.0 (583.0; 982.5) | |
| Intrauterine growth restriction | 65 (21.7%) | 33 (19.8%) | 32 (24.1%) | 0.40 |
| Weight at first UE (g) | 1775.0 (999.8; 2967.5) | 2220.0 (1187.5; 3275.0) | 1280.0 (885.0; 2640.0) | |
| Day of life at first UE | 25.4 (8.6; 65.8) | 19.3 (6.6; 62.5) | 32.9 (13.5; 69.3) | |
| Day of life at admission to Nationwide Children’s NICU | 12.9 (34.6) | 7.9 (25.1) | 19.1 (43.1) | |
| Length of stay (days) | 147.0 (90.0; 214.0) | 107.0 (48.0; 180.0) | 191.5 (137.8; 283.0) | |
| ETT days during NICU stay | 41.0 (15.0; 85.5) | 21.0 (6.0; 56.0) | 62.0 (34.0; 118.0) | |
| Number of ETTs during NICU stay | 3 (2; 6) | 2 (1; 4) | 6 (4; 8) |
Bold values indicate statistical significance p < 0.05.
Data are expressed as n (%), median (IQR), or mean (SD).
UE unplanned extubation, NICU neonatal intensive care unit, ETT endotracheal tube, IQR interquartile range, SD standard deviation.
*P value compares 1 UE vs. ≥2 UE groups.
Events surrounding each UE event and short-term complications.
| Parameter ( | Value |
|---|---|
| ETT securement method | |
| Standard commercial device | 569 (96.8%) |
| Tape | 18 (3.1%) |
| Nasal intubation | 1 (0.2%) |
| Type of ventilation at time of UE | |
| Conventional | 541 (92.0%) |
| High frequency oscillatory ventilation | 47 (8.0%) |
| Skin-to-skin care or holding at time of UE | 96 (16.3%) |
| Primary cause identified | |
| Direct provider contact | 234 (39.8%) |
| Unwitnessed | 23 (3.9%) |
| Emesis | 98 (16.7%) |
| ETT re-taping | 35 (6.0%) |
| Loose securement device or tape | 125 (21.3%) |
| Unknown | 73 (12.4%) |
| Time of day | |
| Day shift (7 a.m.–7 p.m.) | 322 (54.8%) |
| Night shift (7 p.m.–7 a.m.) | 266 (45.2%) |
| Day of week | |
| Monday | 81 (13.8%) |
| Tuesday | 83 (14.1%) |
| Wednesday | 85 (14.5%) |
| Thursday | 87 (14.8%) |
| Friday | 84 (14.3%) |
| Saturday | 84 (14.3%) |
| Sunday | 84 (14.3%) |
| Feeds held | |
| None/already NPO | 516 (87.8%) |
| 1–3 feeds | 60 (10.2%) |
| Made NPO | 12 (2.0%) |
| Resuscitation | |
| None | 328 (55.8%) |
| Bag-mask ventilation to stabilize | 242 (41.2%) |
| Chest compressions | 14 (2.4%) |
| Othera | 4 (0.7%) |
| Death immediately following UE | 2 (0.3%) |
| Airway trauma | |
| None | 527 (89.6%) |
| Mucous membrane bleeding | 20 (3.4%) |
| Airway edema/erythema | 33 (5.6%) |
| Stridor and/or hoarse cry | 8 (1.4%) |
| Reintubated within 60 min of UE | 470 (79.9%) |
| Trial of extubation before reintubation ( | 15 (3.2%) |
| Medications received for reintubation ( | |
| None | 304 (64.7%) |
| Opiate alone | 26 (5.5%) |
| Benzodiazepine alone | 101 (21.5%) |
| Opiate and benzodiazepine | 10 (2.1%) |
| Chloral hydrate | 4 (0.9%) |
| Sedation plus neuromuscular blocker | 25 (5.3%) |
| Number of reintubation attempts ( | |
| 1 | 274 (58.3%) |
| 2 | 113 (24.0%) |
| 3 | 50 (10.6%) |
| ≥4 | 33 (7.0%) |
| Otolaryngology or anesthesia required for reintubation ( | 8 (1.7%) |
| Change to baseline oxygen requirement after reintubation ( | |
| Lower | 69 (14.7%) |
| No change | 217 (46.2%) |
| Increased 1–10% | 136 (28.9%) |
| Increased >10% | 48 (10.2%) |
| Depth of new ETT compared to previous ( | |
| Less deep | 32 (6.8%) |
| Same depth | 230 (48.9%) |
| 0.5–1 cm deeper | 173 (36.8%) |
| >1 cm deeper | 10 (2.1%) |
| Previous depth unknown or not documented | 25 (5.3%) |
| Reintubation alternative ( | |
| Room air | 13 (11.0%) |
| Low flow nasal cannula | 6 (5.1%) |
| High flow nasal cannula | 10 (8.5%) |
| Continuous positive airway pressure | 89 (75.4%) |
Data are expressed as n (%).
UE unplanned extubation, ETT endotracheal tube, NPO nil per os.
aIncluding treatment for bronchospasm and pulmonary hemorrhage.
Number of patients experiencing adverse short-term outcomes following any UE.
| Parameter | 1 UE ( | ≥2 UE ( | |
|---|---|---|---|
| Being held at time of any UE | 27 (16.2%) | 50 (37.6%) | |
| Any number of feeds held after a UE | 22 (13.2%) | 38 (28.6%) | |
| Made NPO after a UE | 7 (4.2%) | 4 (3.0%) | 0.76 |
| Required any resuscitation | 45 (26.9%) | 104 (78.2%) | |
| Required bag-mask ventilation | 45 (26.9%) | 104 (78.2%) | |
| Required chest compressions | 3 (1.8%) | 11 (8.3%) | |
| Any documented airway trauma | 18 (10.8%) | 35 (26.3%) | |
| Any medication administered for reintubation | 28 (16.8%) | 60 (45.1%) | |
| Any benzodiazepine given for reintubation | 8 (4.8%) | 48 (36.1%) | |
| Any opiate given for reintubation | 28 (16.8%) | 25 (18.8%) | 0.65 |
| Any neuromuscular blocker given for reintubation | 12 (7.2%) | 14 (10.5%) | 0.31 |
| Ever reintubated within 60 min of UE | 100 (59.9%) | 91 (68.4%) | 0.15 |
| Ever needed >1 attempt at reintubation | 35 (21.0%) | 99 (74.4%) | |
| Ever needed >2 attempts at reintubation | 15 (9.0%) | 55 (41.4%) | |
| Ever needed otolaryngology or anesthesia for reintubation | 1 (0.6%) | 5 (3.8%) | 0.09 |
| Ever had baseline oxygen requirement increased by >10% after UE | 33 (19.8%) | 44 (33.1%) |
Bold values indicate statistical significance p < 0.05.
Data are expressed as N (%).
UE unplanned extubation, NPO nil per os.
Characteristics and outcomes of those patients with ≥2 UEs compared to those with 1 UE.
| Parameter | 1 UE ( | ≥2 UE ( | Crude OR | Adjusted ORa | Weighted and adjusted ORb | |
|---|---|---|---|---|---|---|
| Weight at first UE < 2000 g | 75 (44.9%) | 86 (64.7%) | 2.24 (1.41; 3.60) | 1.28 (0.68, 2.38) | 1.29 (0.69, 2.40) | 0.42 |
| PMA at first UE < 30 weeks | 39 (23.4%) | 55 (41.4%) | 2.31 (1.41; 3.83) | 1.74 (0.92, 3.31) | 2.01 (1.06, 3.83) | |
| DOL at first UE < 30 days | 89 (53.3%) | 72 (54.1%) | 1.03 (0.66; 1.64) | 0.88 (0.52, 1.48) | 0.83 (0.47, 1.44) | 0.50 |
| Length of stay >90 days | 101 (60.5%) | 120 (90.2%) | 7.64 (3.87; 16.45) | 2.21 (0.92, 5.69) | 3.12 (1.08, 9.03) | |
| Critical airway | 6 (3.6%) | 3 (2.3%) | 0.62 (0.13; 2.39) | 2.09 (0.35, 11.17) | 1.31 (0.26, 6.68) | 0.75 |
| Chromosomal anomaly/genetic syndromec | 18 (10.8%) | 15 (11.3%) | 1.05 (0.51; 2.17) | 1.89 (0.66, 5.59) | 2.32 (0.72, 7.47) | 0.16 |
| Mortality during initial hospitalization | 22 (13.2%) | 14 (10.5%) | 0.81 (0.39; 1.63) | 0.41 (0.16, 0.99) | 0.41 (0.16, 1.08) | 0.07 |
| Bronchopulmonary dysplasia | 96 (57.5%) | 119 (89.5%) | 7.81 (3.96; 16.92) | 3.08 (0.88, 11.73) | 6.78 (1.42, 32.31) | |
| Tracheostomy | 18 (10.8%) | 35 (26.3%) | 2.96 (1.59; 5.61) | 3.03 (1.38, 6.95) | 4.16 (1.68, 10.31) |
Bold values indicate statistical significance p < 0.05.
Data are expressed as N (%) or odds ratio (95% confidence interval).
UE unplanned extubation, OR odds ratio, PMA postmenstrual age, DOL day of life, IPTW inverse probability of treatment weighting.
*P values are displayed from weighted and adjusted models.
aAdjusted odds ratios displayed as adjusted for sex, gestational age, birth weight, and total number of ETT days during initial hospitalization.
bWeighted and adjusted ORs are IPTW weighted for sex, gestational age, and birth weight; and adjusted for sex, gestational age, birth weight, and total number of ETT days during initial hospitalization.
cIncluding Trisomy 21, Stickler syndrome, CHARGE syndrome, Wolff–Hirschhorn syndrome, DiGeorge syndrome, and a chromosome 19 anomaly.
Characteristics of those patients with acquired SGS compared to those without acquired SGS.
| Outcomes | No SGS ( | SGS ( | Crude OR | Adjusted ORa | Weighted and adjusted ORb | |
|---|---|---|---|---|---|---|
| Postmenstrual age at first UE < 32 weeks | 116 (42.6%) | 6 (21.4%) | 0.37 (0.13, 0.88) | 0.44 (0.15, 1.19) | 0.40 (0.15, 1.07) | 0.07 |
| Weight at first UE < 1500 g | 128 (47.1%) | 7 (25.0%) | 0.38 (0.14, 0.87) | 0.37 (0.13, 0.96) | 0.34 (0.13, 0.91) | |
| DOL at first UE < 21 days | 122 (44.9%) | 11 (39.3%) | 0.80 (0.35, 1.74) | 0.77 (0.34, 1.7) | 0.73 (0.32,1.67) | 0.46 |
| ≥ 4 UEs | 30 (11.0%) | 8 (28.6%) | 3.23 (1.25, 7.75) | 3.54 (1.19, 10.07) | 4.25 (1.35,13.45) | |
| ≥ 3 reintubation attempts following any UE | 63 (23.2%) | 7 (25.0%) | 1.11 (0.42, 2.61) | 0.97 (0.36, 2.36) | 0.91 (0.36, 2.27) | 0.83 |
| ≥ 4 ETTs during hospitalization | 124 (45.6%) | 19 (67.9%) | 2.52 (1.13, 6.03) | 2.22 (0.77, 6.68) | 2.79 (0.98, 7.93) | 0.06 |
| Sherman ratio ≥0.1c for any ETT | 20 (7.4%) | 1 (3.6%) | 0.86 (0.05, 4.92) | 0.95 (0.05, 5.77) | 0.94 (0.15,5.98) | 0.95 |
| Airway trauma with reintubation | 41 (15.1%) | 12 (42.9%) | 4.23 (1.83, 9.56) | 4.31 (1.81, 10.19) | 5.66 (2.15, 14.87) | |
| Tracheitis | 35 (12.9%) | 18 (64.3%) | 12.19 (5.31, 29.53) | 12.4 (4.99, 32.81) | 13.16 (5.04, 34.35) | |
| Chromosomal anomaly/genetic syndromed | 25 (9.2%) | 8 (28.6%) | 3.95 (1.51, 9.65) | 4.55 (1.44, 14.26) | 5.62 (1.49, 21.13) |
Bold values indicate statistical significance p < 0.05.
Data are expressed as N (%) or odds ratio (95% confidence interval).
SGS subglottic stenosis, OR odds ratio, UE unplanned extubation, DOL day of life, ETT endotracheal tube, IPTW inverse probability of treatment weighting.
*P values are displayed from weighted and adjusted models.
aAdjusted odds ratios displayed as adjusted for sex, gestational age, birth weight, and total number of ETT days during initial hospitalization.
bWeighted and adjusted ORs are IPTW weighted for sex, gestational age, and birth weight; and adjusted for sex, gestational age, birth weight, and total number of ETT days during initial hospitalization.
cSherman ratio = ETT size/gestational age.
dTrisomy 21, Stickler syndrome, CHARGE syndrome, Wolff–Hirschhorn syndrome, DiGeorge syndrome, and a chromosome 19 anomaly.